Fair point - I assume the choice of the word 'rapid' is used in this case to signify results that are out of the ordinary.
Hopefully these sorts of results start to sway those at the FDA with respect to Rem-L's ability to demonstrate treatment effect as they certainly had some doubts in the GvHD briefing papers.
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-53
-
- There are more pages in this discussion • 371 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |